Published in:
01-01-2013 | Short Communication
Herpes zoster infection, vaccination and immunocompromised rheumatology patients
Authors:
Mortimer B. O’Connor, Mark J. Phelan
Published in:
Rheumatology International
|
Issue 1/2013
Login to get access
Abstract
Varicella is a self-limiting and relatively mild disease of childhood, although it is frequently more severe and complicated among the immunocompromised rheumatology patients on immunomodulator therapies. In addition, future reactivation of the dormant virus in dorsal root ganglia may cause herpes zoster infection, which can be very debilitating. In this manuscript, we discuss the nature of this infection along with its potential vaccine especially among rheumatology patients.